Comparative results of treatment for chronic hepatitis C in HIV-infected patients receiving and not receiving highly active antiretroviral therapy



Cite item

Full Text

Abstract

The paper presents the comparative results of treatment for chronic hepatitis C in HIV-infected patients in two groups: those who receive and do not receive highly active antiretroviral therapy (HAART). The findings indicated that the efficiency of therapy for hepatitis was comparable in both groups: the proportions of patients with a steady-state virological response who received and did not receive HAART were 34.1 and 40.9%, respectively. Some adverse reactions significantly differed in their frequency in both groups. Nevertheless, their severity was that which did not require hepatitis therapy discontinuance.

About the authors

S V Minayeva

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Email: mistella@yandex.ru
Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

G F Moshkovich

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

M P Goryaeva

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

L V Varlova

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

I D Voronina

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

References

  1. Методические рекомендации Федерального научно-методического центра по профилактике и борьбе со СПИДом Роспотребнадзора "Диспансерное наблюдение, лечение и профилактика вирусных гепатитов у подростков и взрослых, больных ВИЧ-инфекцией" / Кравченко А. В., Ганкина Н. Ю., Канестри В. Г. и др. - М., 2007.
  2. Кравченко А. В., Ганкина Н. Ю., Канестри В. Г. Особенности антиретровирусной терапии при сочетании ВИЧ-инфекции и хронического вирусного гепатита // Фарматека. - 2008. № 19. - С. 1-8.
  3. Шахгильдян В. И. Современные подходы к лечению HCV-инфекции у ВИЧ-инфицированных // Гепатол. форум. - 2008. - № 4. - С. 16-27.
  4. Bannister W. P., Mocroft A. et al. Opportunistic infections in immunocompromised but virologically suppressed HIV-1 infected patients // 9-th International Congress on Drug Therapy in HIV Infection, Glazgow, UK, 9-13 Nov., 2008. - Glazgow, 2008. - P. 13.
  5. Crum N. F., Riffenburgh R. H., Wegner S. et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early and late HAART eras // J. Acquir. Immune Defic. Syndr. - 2006. - Vol. 41. - P. 194-200.
  6. Laguno M., Murillas J., Blanco J. L. et al. Peginterferon Alfa-2b plus ribavirin compared with interferon Alfa-2b plus ribavirin for treatment HIV/HCV coinfected patients // AIDS. - 2004. - Vol. 18. - P. F27-F36.
  7. Mallolas J., Laguno M. Peginterferon Alfa-2b plus ribavirin for treatment naive patients coinfected with HCV and HIV // Expert. Rev. Antiinfect. Ther. - 2008. - Vol. 6. - P. 281-289.
  8. Moshkovich G., Minaeva S., Tichonova E., Sandova 0. HCV Genotypes distribution in the Nizhny Novgorod area HIV-positive population // 9-th International Congress on Drug Therapy in HIV Infection, Glazgow, UK, 9-13 Nov., 2008. - Glazgow, 2008. - P. 110.
  9. Soriano V., Barriero P., Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients // J. Antimicrob. Chemother. - 2006. - Vol. 57. - P. 815-818.

Copyright (c) 2010 Eco-vector



Свидетельство о регистрации СМИ № 014448 от 08.02.1996 г. выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор). 
Свидетельство о регистрации СМИ ЭЛ № ФС 77 - 80652 от 15.03.2021 г. выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies